Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

$100 Invested In ASML Holding 20 Years Ago Would Be Worth This Much Today

ASML Holding (NASDAQ:ASML) has outperformed the market over the past 20 years by 11.07% on an annualized basis producing an average annual return of 18.37%. Currently, ASML Holding has a market capitalization of $205.89 billion.

Marvell Tech Whale Trades For June 24

Marvell Tech Whale Trades For June 24

A whale with a lot of money to spend has taken a noticeably bearish stance on Marvell Tech. Looking at options history for Marvell Tech (NASDAQ:MRVL) we detected 35 strange trades.

$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today

$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today

Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 3.97% on an annualized basis producing an average annual return of 10.41%. Currently, Amgen has a market capitalization of $130.40 billion.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks Rebound From 2022 Lows As Market Digests Fed Chair Powell's Congressional Testimony

The SPDR S&P 500 ETF Trust (NYSE: SPY) bounced back from its recent weakness in a holiday-shortened trading week, with all major indexes trading higher.

Terran Orbital Installs CAPSTONE Aboard Rocket Lab Electron Rocket

Terran Orbital Corp (NYSE:LLAP) revealed the successful integration of the CAPSTONE spacecraft aboard the Rocket Lab USA, Inc (NASDAQ:RKLB) Rocket Lab Electron rocket. Terran Orbital designed and built satellite is flying a pathfinding mission to the moon in support of NASA's Artemis program. LLAP's team produced CAPSTONE's hardware, assembled and tested the spacecraft, and integrated…

Here's Why American Airlines Stock Looks Ready For Takeoff

American Airlines Group, Inc (NASDAQ: AAL) was flying about 7% higher on Friday, in tandem with the S&P 500, which was surging about 2.4% higher.

Meta's Biggest Rival Posts Visible Success On Gaming Foray Despite Bigger Rivals Like Tencent, NetEase

TikTok parent ByteDance Ltd's gaming foray exudes promise as spending across its mobile titles grew over the past year, according to Sensor Tower. The report highlighted TikTok owner generated $1 billion of player spending across its mobile games as of the year ended June 20, 2022, up 16% year-on-year. ByteDance had set…

inkl

Read news from The Economist, FT, and more,
with one subscription

Nasdaq Surges 300 Points; USA Truck Shares Spike Higher

Nasdaq Surges 300 Points; USA Truck Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining 300 points on Friday.

Futu Bull-Bear Debate: Does The Recent Rally In Chinese Stocks Have Legs?

Futu Bull-Bear Debate: Does The Recent Rally In Chinese Stocks Have Legs?

Chinese online brokerage platform Futu Holdings Ltd (NASDAQ: FUTU) is understandably a polarizing topic among analysts and investors.

Is Advanced Micro Devices Headed For Gap Fill Or Will This Bearish Pattern Dominate?

Is Advanced Micro Devices Headed For Gap Fill Or Will This Bearish Pattern Dominate?

Advanced Micro Devices, Inc. (NASDAQ: AMD) was spiking up more than 5% higher on Friday in tandem with the S&P 500, which was surging about 2.5% higher.

Where Pear Therapeutics Stands With Analysts

Where Pear Therapeutics Stands With Analysts

Within the last quarter, Pear Therapeutics (NASDAQ:PEAR) has observed the following analyst ratings:

Craig-Hallum Cuts Apogee Enterprises Price Target By ~9%

Craig-Hallum Cuts Apogee Enterprises Price Target By ~9%

Craig-Hallum analyst Eric Stine lowered the price target for Apogee Enterprises Inc (NASDAQ:APOG) to $43 (2.7% upside) from $47 while maintaining the Hold rating on the shares. The analyst noted the company had a good start to FY23, with Q1 surpassing expectations. Stine expressed optimism about Apogee's operational progress. Meanwhile, the analyst specified that certain market…

10 Communication Services Stocks Whale Activity In Today's Session

10 Communication Services Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

10 Information Technology Stocks With Whale Alerts In Today's Session

10 Information Technology Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Get all your
news in one place.

100's of premium titles.
One news app.

Looking At Activision Blizzard's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Activision Blizzard (NASDAQ:ATVI). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Here's How Much $1000 Invested In Advanced Micro Devices 5 Years Ago Would Be Worth Today

Advanced Micro Devices (NASDAQ:AMD) has outperformed the market over the past 5 years by 35.35% on an annualized basis producing an average annual return of 45.28%. Currently, Advanced Micro Devices has a market capitalization of $140.52 billion.

Why Shares Of LendingTree Are Trading Lower Today

LendingTree, Inc. (NASDAQ: TREE) shares are trading lower after the company cut its second quarter revenue guidance.

New Bipartisan Bill Would Allow Cannabis Stocks To Access Financial Services And List On NYSE, NASDAQ

Rep. Troy A. Carter (D-LA) and Rep. Guy Reschenthaler (R-PA) presented a new bill Thursday that aims to provide many benefits to the challenging cannabis industry.

Get all your
news in one place.

100's of premium titles.
One news app.

Why Shares Of Penn National Are Trading Higher Today

Penn National Gaming, Inc. (NASDAQ: PENN) shares are trading higher alongside several other hotel, restaurant & leisure companies stocks rebound following last week's selloff.

Ad Industry's Biggest Conference Returns With New Winner: Find Out Who

The advertising industry's biggest conference has returned with a new winner Amazon.com, Inc (NASDAQ: AMZN), after a two-year break, Bloomberg reports. Amazon occupied a portion of the beachfront at the annual Cannes Lions show with the "Amazon Port," its most extensive showcasing at the conference yet reflecting its growing significance. Tech companies like Alphabet Inc (NASDAQ:GOOG)…

Rosenblatt Sees Splunk 'Attractive' At Current Levels - Read Why

Last week, Splunk Inc (NASDAQ: SPLK) held its annual conference, during which it made several products and partner announcements.

Here's How Much $100 Invested In Applied Materials 5 Years Ago Would Be Worth Today

Applied Materials (NASDAQ:AMAT) has outperformed the market over the past 5 years by 8.36% on an annualized basis producing an average annual return of 18.27%. Currently, Applied Materials has a market capitalization of $84.32 billion.

Here's Why Credit Suisse Sees Tesla Triumph Amid Odds

Credit Suisse analyst Dan Levy maintained Tesla Inc (NASDAQ:TSLA) with an Outperform and cut the price target from $1,125 to $1,000 (37% upside). Levy expected Tesla's 2Q deliveries of 242,000, missing the consensus of ~280,000 due to the Shanghai COVID shutdown. Moreover, given the lower delivery outlook, the associated margin impact, and an expected Bitcoin impairment, he…

Filsuvez's European Approval Adds Growth Driver For Amryt Pharma

Yesterday, Amryt Pharma plc (NASDAQ:AMYT) received European approval for Filsuvez for partial thickness wounds associated with dystrophic and junctional Epidermolysis Bullosa (EB) in patients six months and older. Filsuvez becomes the first approved treatment for EB. HC Wainwright notes that the Medicines and Healthcare products Regulatory Agency in the U.K. is expected to grant authorization…

Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis

Intellia Therapeutics Inc (NASDAQ:NTLA) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced additional interim data from the Phase 1 study of NTLA-2001, in vivo genome editing candidate for transthyretin (ATTR) amyloidosis. Intellia had said that at the highest dose level (1.0mg/kg), six patients had shown a 93% mean reduction in the toxic protein. In the new data,…

1 … 401 402 403 404

People

Blair Abernethy

Guy Reschenthaler

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

American Airlines

Amazon.com Inc.

Activision Blizzard

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

386,891 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play